JWH-307

JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors. It is somewhat selective for the CB 2 subtype, with a K i of 7.7 nM at CB 1 vs 3.3 nM at CB 2 . It was discovered by, and named after, John W. Huffman.

JWH-307 was detected as an ingredient in synthetic cannabis smoking blends in 2012, initially in Germany. In the United States, CB 1 receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-307 are Schedule I Controlled Substances.

JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors. It is somewhat selective for the CB 2 subtype, with a K i of 7.7 nM at CB 1 vs 3.3 nM at CB 2 . It was discovered by, and named after, John W. Huffman.

JWH-307 was detected as an ingredient in synthetic cannabis smoking blends in 2012, initially in Germany. In the United States, CB 1 receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-307 are Schedule I Controlled Substances.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1373290920 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.